Relationship between clinical outcomes and nerve conduction studies before and after surgery in patients with carpal tunnel syndrome by Ise, Masato et al.
Ise et al. BMC Musculoskelet Disord          (2021) 22:882  
https://doi.org/10.1186/s12891-021-04771-y
RESEARCH
Relationship between clinical outcomes 
and nerve conduction studies before and after 
surgery in patients with carpal tunnel syndrome
Masato Ise1,2, Taichi Saito1*, Yoshimi Katayama2, Ryuichi Nakahara1, Yasunori Shimamura3, Masanori Hamada2, 
Masuo Senda2 and Toshifumi Ozaki1 
Abstract 
Background: Nerve conduction study (NCS) is the only useful test for objective assessment of carpal tunnel syn-
drome (CTS). However, the relationship between pre- and postoperative NCS and clinical outcomes was unclear. This 
study aimed to determine whether pre- and postoperative (6 months) NCS could predict patient-oriented and motor 
outcomes (6 and 12 months postoperatively) in patients with CTS.
Method: Of the 85 patients with CTS, 107 hands were analyzed from March 2011 to March 2020. All patients 
underwent open carpal tunnel release and were examined using the disabilities of the arm, shoulder and hand 
(DASH) questionnaire and grip strength (GS) preoperatively and 6 and 12 months postoperatively. Moreover, NCS was 
examined preoperatively and 6 months postoperatively. Distal motor latency (DML) and sensory conduction velocity 
(SCV) were the parameters used for NCS. The correlation coefficient between NCS and DASH or GS was calculated. 
A receiver operating characteristic curve was utilized to determine the NCS threshold value to predict DASH and GS 
improvement.
Results: The average scores of GS preoperatively and 6 and 12 months postoperatively were 21.3, 22.3, and 22.8, 
respectively. On the other hand, the average scores of DASH preoperatively and 6 and 12 months postoperatively 
were 28.8, 18.3, and 12.2, respectively. The average NCS scores (DML and SCV) preoperatively/6 months postop-
eratively were 7.3/5.4 and 27.8/36.7, respectively. Preoperative NCS did not correlate with DASH and GS. Postop-
erative SCV correlated with the change in grip strength (6–12 months, r = 0.67; 0–12 months, r = 0.60) and DASH 
(0–12 months, r = 0.77). Moreover, postoperative DML correlated with the change in DASH (6–12 months, r = − 0.33; 
0–12 months, r = − 0.59). The prediction for the improvement of GS/DASH achieved a sensitivity of 50.0%/66.7% and 
a specificity of 100%/100%, at an SCV cutoff score of 38.5/45.0 or above. The prediction for improvement of GS/DASH 
achieved a sensitivity of 83.3%/66.7% and a specificity of 100%/66.7% at a DML cutoff score of 4.4/4.4 or below.
Conclusion: NCS at 6 months postoperatively can be used to predict the improvement of clinical outcome after 
6 months postoperatively in patients with CTS.
Keywords: Carpal tunnel syndrome, Nerve conduction study, The disability of the arm, shoulder and hand 
questionnaire, Clinical outcomes
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Background
Carpal tunnel syndrome (CTS) is the most frequent 
entrapment neuropathy. In the general population, the 
prevalence of CTS is reported to be 3.8–10% [1, 2], and 
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among people > 50 years old in Japan, it is reported to be 
5.1% [3].
Clinical manifestation and physical findings are used 
to diagnose CTS. Nerve conduction study (NCS) help 
to diagnose and decide on the treatment plan (conserva-
tive treatment or surgery) as well as predict the surgery 
prognosis for patients with CTS [4]. Furthermore, NCS 
is the only useful test for objective CTS assessment. NCS 
and the clinical symptom severity scale were found to be 
correlated [5]. Moreover, NCS was reported as a predic-
tor of poor outcomes for surgical release [6]. The clini-
cal success of surgical release for CTS occurs at a rate of 
75–90%, whereas the recurrence is reported in 4–57% of 
cases [7]. Thus, predicting clinical outcomes following 
surgical release is very useful for patients and surgeons.
However, the relationship between clinical outcomes 
following surgical release and pre−/postoperative NCS 
is unclear. In addition, few studies have reported a cor-
relation between NCS and motor outcome (e.g., power or 
pinch grip). This study aimed to examine the prediction 
improvement in patient-oriented and motor outcomes 
after operation using preoperative NCS. Furthermore, 
whether NCS at 6 months postoperatively can predict 
clinical outcomes at 12 months postoperatively was 
investigated.
Methods
This study analyzed 107 hands of 85 patients with CTS 
from March 2011 to March 2020. All patients under-
went open carpal tunnel release (OCTR), which was 
performed by two orthopedic hand surgeons. CTS was 
diagnosed based on the patient’s medical history, thenar 
muscle atrophy, NCS, and physical examination (e.g., 
ring-finger splitting, Tinel-like sign, and Phalen’s test). 
Electrodiagnostic criteria used to diagnose CTS in this 
study was median distal motor latency from the wrist to 
abductor pollicis brevis < 4.0 ms [8] and median motor 
nerve conduction velocity < 45 m/s from the wrist to 
abductor pollicis brevis and median sensory nerve con-
duction velocity < 45 m/s in the third digit to wrist [9]. We 
set the lower limit value of amplitude of compound mus-
cle action potential (CMAP) and sensory nerve action 
potential (SNAP) of median nerve at wrist stimulation 
was 3.5 mV and 10 μV respectively [9, 10].
The patients underwent NCS preoperatively and 
6 months postoperatively. Grip strength was also meas-
ured, and disabilities of the arm, shoulder and hand 
(DASH) questionnaire was administered before surgery 
and at the time of outpatient visits at 6 and 12 months 
postoperatively. Patients with rheumatoid arthritis, arti-
ficial dialysis, polyneuropathy, and unavailable NCS 
waveform at the median nerve were excluded. Finally, 85 
hands of 67 patients were included in this study.
This study was approved by the institutional eth-
ics committee at Okayama University Hospital, and 
informed consent was obtained in the opt-out form on 
the website.
NCS was conducted using a Neuropack MEB-2300 
(Nihon Kohden, Tokyo, Japan). The filter settings were 
between 20 and 2000 Hz. Stimulation was performed 
with a square wave pulse of 0.2-ms duration. The com-
pound muscle action potential, distal motor latency, and 
motor nerve velocity of the median nerve were recorded 
via orthodromic stimulation at the wrist, 70-mm proxi-
mal to recording electrodes placed over the abductor 
pollicis brevis muscle. Sensory nerve conduction veloc-
ity (SCV) was recorded via antidromic stimulation at the 
wrist, 140-mm proximal to recording electrodes placed 
over the proximal phalanx of the middle finger using ring 
electrodes around the proximal and middle phalanxes of 
the middle finger. The skin temperature of the hand was 
maintained between 32 °C and 34 °C. Grip strength was 
measured using Smedley hand dynamometer (Igarashi 
Ikakougyou, Tokyo, Japan).
Grip strength and DASH were used as parameters for 
objective and patient-oriented assessments, respectively. 
DASH is a self-administered questionnaire consisting of 
a disability/symptom (DASH-DS) scale and two optional 
modules, namely, work and sport/music modules. 
Moreover, it was widely used for shoulder, hand, elbow, 
and wrist problem evaluations. The patients were asked 
to achieve a score of 1–5 on all 30 items, and the scores 
increased with the increase in disability. The obtained 
raw score was then converted to a 0–100 scale. The reli-
ability, validity, and responsiveness of the Japanese ver-
sion of DASH had equivalent evaluation capacity to those 
of the DASH original versions [11]. Moreover, this study 
focused on the score of the DASH-DS scale.
The prediction of functional prognosis following sur-
gical release using NCS was explored using the receiver 
operating characteristic (ROC) curve. A previous study 
reported the minimal clinically important differences 
(MCID) for DASH in patients with isolated tendini-
tis, arthritis, or nerve compression syndromes [12–14]. 
Therefore, a cutoff score of > 10 for postoperative clini-
cal improvement in DASH was set. Although no study 
on the MCID of grip strength in patients with CTS was 
conducted, the MCID of grip strength was estimated to 
be 2.69–2.44 kg in the healthy group without conditions 
[15]. Thus, we set a cutoff value of > 2 kg for postopera-
tive clinical grip strength improvement. Moreover, the 
ROC curve is a commonly used statistical graphical plot 
to help evaluate the performance of a diagnostic test by 
plotting the true-positive (sensitivity) rate against the 
false-positive (1-specificity) rate at various threshold 
settings. Youden’s criterion was used to select the ideal 
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cutoff point in order to determine the result of the NCS 
on the ROC curve. The efficacy of the NCS to predict 
functional prognosis was described using an area under 
the curve (AUC), sensitivity, specificity, and positive and 
negative likelihood ratios.
Statistical analyses were conducted using the Bell 
Curve (Social Survey Research Information Co., Ltd., 
Shinjuku-ku, Japan) with the significance level set at 
< 0.05 for all statistical tests. The correlations between the 
results of preoperative NCS and clinical outcomes that 
include grip strength and DASH score were assessed via 
a nonparametric test (Spearman’s correlation).
Results
Participant characteristics
Table 1 presents the patients’ characteristics. This study 
included 67 (18 men and 49 women) patients, and 85 
hands with CTS were analyzed. The average age was 
64.5 years ([SD] = 13.3; range = 34–87), and the average 
symptom duration was 19.5 months (range = 2–72). No 
reoperation cases were included in this study.
NCS and clinical outcomes (grip strength and DASH score)
The mean pre−/postoperative values at 6 and 12 months 
for grip strength, DASH, and NCS results are presented 
in Table  2. Grip strength at 6 and 12 months postop-
eratively improved by an average of 1.9 kg (0–6 months, 
95% confidence interval [CI] = 0.5–3.4) and 3.7 kg 
(6–12 months, 95% CI = 2.6–4.9), respectively, compared 
with preoperative measurements. Improvement in grip 
strength between 6 and 12 months postoperatively was 
higher compared with that between preoperative and 
6 months postoperatively. Grip strength in all patients 
at 12 months postoperatively improved compared with 
preoperative measurements. The average DASH scores 
increased to 11.9 (0–6 months, 95% CI = 3.2–20.6) and 
14.1 (6–12 months, 95% CI = 2.1–26.1), respectively. The 
improvement in DASH score between 6 and 12 months 
postoperatively was also higher compared with that 
between preoperatively and 6 months postoperatively. 
The results of NCS were improved between preoperative 
and 6 months postoperatively.
Relationships between nerve conduction measures 
and clinical outcome
Tables  3 and 4 present the correlation coefficients 
between pre−/postoperative NCS and change in the 
grip strength and DASH scores at 6 and 12 months post-
operatively. A no significant correlation was observed 
between preoperative NCS (SCV) and change in the 
grip strength scores (0–6 months, r = 0.23; 6–12 months, 
r = 0.21; 0–12 months, r = 0.27). Moreover, a signifi-
cant correlation was not observed between preoperative 
NCS (SCV) and change in DASH scores (0–6 months, 
r = 0.16; 6–12 months, r = − 0.03; 0–12 months, r = 0.26). 
SCV at 6 months postoperatively had modest and signifi-
cant correlation with the change in grip strength scores 
(6–12 months, r = 0.67; 0–12 months, r = 0.60) and DASH 
score (0–12 months, r = − 0.59). NCS (DML) at 6 months 
postoperatively had no correlation with the change in 
grip strength scores but modest and significant corre-
lation with the change in DASH scores (6–12 months, 
r = 0.12; 0–12 months, r = 0.77).
Similarly, no significant correlation was observed 
between amplitudes of preoperative CMAP and SNAP 
and change in the grip strength and DASH scores at 
6 and 12 months postoperatively. The amplitude of 
CMAP at 6 months postoperatively had modest and 
Table 1 Clinical characteristics of patients
mo months
Characteristics Values
Age (years ± SD) 64.5 ± 13.3
Female (n/%) 49/73
Rt operated hand (n) 49
Duration of symptoms (mo, range) 19.5 (2–72)
Table 2 Average preoperative and postoperative values
DASH Disabilities of Arm, Shoulder and Hand, DML Distal motor latency (ms), SCV Sensory conduction velocity (m/s), CMAP Compound muscle action potential (mV), 
SNAP Sensory nerve action potential (μV), SD Standard deviation
Preoperative 6 months 12 months
Average (SD) Range Average (SD) Range Average (SD) Range
Grip 21.3 (10.3) 5–61.8 22.3 (10.5) 8–69.9 22.8 (5.6) 10–35.9
DASH 28.8 (19.5) 0–94.4 18.3 (13.5) 0–49.1 12.2 (8.5) 1–28
Median
 DML 7.3 (6.6) 4–18.2 5.4 (5.9) 0–8.0
 SCV 27.8 (7.3) 9.4–46.8 36.7 (10.7) 0–54.9
CMAP amplitude 3.8 (3.0) 0.1–12.7 4.2 (3.0) 0–12.0
Page 4 of 9Ise et al. BMC Musculoskelet Disord          (2021) 22:882 
significant correlation with the change in grip strength 
scores (0–6 months, r = 0.41; 6–12 months, r = 0.43; 
0–12 months, r = − 0.04).
We also compared the postoperative clinical out-
comes between two groups divided by the lower limit 
of the CMAP amplitude (3.5 mV) at pre- and 6 months 
post-surgery to investigate the effect of the electro-
physiologic pathology on clinical outcomes. There was 
no significant difference between the two groups (Sup-
plementary Tables 1 and 2).
Area under the curve in the receiver operating 
characteristic curve analysis
An NCS ROC analysis at 6 months postoperatively (SCV, 
DML) was conducted to set a cutoff point for predicting 
grip strength and DASH improvements at 12 months. 
The SCV results on grip strength demonstrated that the 
AUC was 0.67 (Fig.  1; 95% CI for AUC, 0.20–1,13). A 
cutoff value of 38.5 m/s higher for SCV predicts improve-
ment with sensitivity and specificity of 50.0 and 100%, 
respectively. The DML results indicated that the AUC 
Table 3 Spearman’s correlation coefficients between preoperative nerve conduction measures and difference in grip strength and 
DASH
Instrument scale 0–6 Difference of GP 6–12 Difference of GP 0–12 Dif-
ference of 
GP
DML (ms) − 0.26 0.07 − 0.15
SCV (m/s) 0.23 0.21 0.27
CMAP amplitude (mV) 0.04 −0.07 −0.36
SNAP amplitude (μV) 0.04 0.14 0.13




DML (ms) −0.01 − 0.1 − 0.03
SCV (m/s) 0.16 −0.03 0.26
CMAP amplitude (mV) −0.16 −0.28 − 0.49
SNAP amplitude (μV) −0.20 0.28 0.11
Table 4 Spearman’s correlation coefficients between 6 months postoperative nerve conduction measures and difference in grip 
strength and DASH
* P < 0.05
Instrument scale 0–6 Difference of GP 6–12 Difference of GP 0–12 Dif-
ference of 
GP
Post 6 month DML − 0.24 −0.002 − 0.13
Post 6 month SCV 0.31 0.67* 0.60
Post 6 month CMAP 0.41* 0.43 −0.04
Post 6 month SNAP 0.12 0.08 −0.19




Post 6 month DML 0.60* 0.12 0.77*
Post 6 month SCV −0.23 −0.33 − 0.59
Post 6 month CMAP amplitude 0.26 −0.23 − 0.45
Post 6 month SNAP amplitude − 0.07 0.09 − 0.38
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was 0.91 (Fig.  2; 95% CI for AUC, 0.69–1.15). A cutoff 
value of 4.4 ms lower for DML predicts improvement 
with sensitivity and specificity of 83.3 and 100%, respec-
tively. The SCV results on DASH improvement indicated 
that the AUC was 0.83 (Fig.  3; 95% CI for AUC, 0.48–
1,19). A cutoff value of 45.0 m/s lower for SCV predicts 
improvement with sensitivity and specificity of 66.7 and 
100%, respectively. The DML results demonstrated that 
the AUC was 0.72 (Fig. 4; 95% CI for AUC, 0.33–1,11). A 
cutoff value of 4.4 ms higher for DML predicts improve-
ment with sensitivity and positive predictive value of 66.7 
and 66.7%, respectively.
Fig. 1 A graph showing the ROC curve for predicting improvement of > 2 kg in grip strength based on SCV at 6 months postoperatively. The actual 
area under the curve (AUC,0.67 [95% CI, 0.20 to 1.13]). The best cutoff point of SCV for balancing sensitivity and specificity was 38.5
Fig. 2 A graph showing the ROC curve for predicting improvement of > 2 kg in grip strength based on DML at 6 months postoperatively. The actual 
area under the curve (AUC,0.91 [95% CI, 0.69 to 1.15]). The best cutoff point of DML for balancing sensitivity and specificity was 4.4
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Discussion
This retrospective study found a moderate and significant 
correlation between NCS (SCV) and the change in the 
grip strength and DASH scores at 6 and 12 months post-
operatively. However, a no significant correlation exists 
between preoperative NCS and clinical outcomes (DASH 
and grip strength).
The clinical success rate of OCTR was reported to be 
about 75–90% [16]. Thus, the prediction of postoperative 
clinical outcomes for patients and surgeon is beneficial. 
For surgeons, the prediction of the postoperative clinical 
course is helpful for the selection of patients with poor 
prognoses as well as explanations for patients and con-
siderations for operation. Several studies were conducted 
Fig. 3 A graph showing the ROC curve for predicting improvement of > 10 in the DASH score based on SCV at 6 months postoperatively. The 
actual area under the curve (AUC,0.83 [95% CI, 0.48 to 1.19]). The best cutoff point of SCV for balancing sensitivity and specificity was 45.0
Fig. 4 A graph showing the ROC curve for predicting improvement of > 10 in the DASH score based on DML at 6 months postoperatively. The 
actual area under the curve (AUC,0.72 [95% CI, 0.33 to 1.11]). The best cutoff point of DML for balancing sensitivity and specificity was 4.4
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using NCS and patient-reported outcomes (PRO) to pre-
dict prognosis following operation [6, 17, 18]. However, 
there are conflicting reports on the severity of conduc-
tion disturbances and surgery outcomes. Heybeli et  al. 
reported that NCS improvements did not correlate with 
improvement in the self-administered Boston Question-
naire preoperatively and 6 months preoperatively [19]. 
Itubo et  al. also reported that no significant correlation 
was observed between the preoperative and 3 months 
postoperative patient-oriented questionnaires and pre-
operative and 3 months postoperative NCS [18]. On the 
other hand, Bland et al. reported that preoperative NCS 
correlated with postoperative clinical outcomes and 
that patients with middle-grade abnormalities achieved 
better results compared with those with severe abnor-
malities [6]. This study demonstrated a no significant 
correlation between preoperative NCS and improvement 
in clinical outcomes (grip strength and DASH). In addi-
tion, the follow-up period was short (within 6 months) 
in most studies that investigated the correlation between 
postoperative clinical outcomes and NCS [13, 18, 20]. 
Furthermore, this study revealed that a significant and 
modest correlation was observed between NCS (SCV) at 
6 months postoperatively and the change in grip strength 
and DASH at 12 months postoperatively.
Setting a threshold value is useful for determining 
CTS severity and predicting clinical outcome prognosis 
following operation. Concerning the threshold value of 
NCS, Bland et  al. reported that distal motor latency to 
abductor pollicis brevis < 6.5 ms was utilized to evaluate 
the severity of CTS [21]. In addition, Lo et  al. reported 
that a cutoff value of 6.0 ms or lower for preoperative 
sensory latency predicts a good outcome (in terms of 
paresthesia score) with sensitivity/certainty and posi-
tive predictive values of 84.6 and 86.8%, respectively, in 
patients with CTS following endoscopic carpal tunnel 
syndrome surgery [13]. This study revealed the improve-
ment in grip strength/DASH at 12 months postop-
eratively in patients with > 38.5 m/s (SCV) and < 4.4 ms 
(DML)/ > 45.0 m/s (SCV) and < 4.4 ms (DML) at 6 months 
postoperatively, respectively. To the best of our knowl-
edge, this study is the first to reveal the NCS threshold 
value to predict PRO and grip strength improvement 
following surgery. Nolan et  al. reported that even at 
66 months postoperatively, only 50% of hands demon-
strated normal DML [22]. This study demonstrated that 
2.4%/1.2% of hands exhibited normal DML/SCV preop-
eratively, and 23%/44% of hands exhibited normal DML/
SCV at 6 months postoperatively. Even if the results of 
NCS at 6 months postoperatively are not normal, the 
results of this study can help predict improvements 
in grip strength and DASH. Thus, these results sug-
gested that NCS at 6 months postoperatively can be used 
not only to evaluate the degree of postoperative NCS 
improvement but also to predict the improvement in grip 
strength/DASH at 12 months postoperatively.
This study used grip strength for postoperative clinical 
motor evaluation. However, there is no consensus as to 
what method for motor function assessment of patients 
with CTS following surgical treatment is the most use-
ful [23]. However, grip strength was one of the major 
objective motor outcomes. Yoshida et  al. reported the 
grip strength-related disability of the upper extremity in 
patients with CTS [24]. Some other studies also used grip 
strength as motor outcomes in patients with CTS follow-
ing surgery [25–29].
Grip strength at 6 months postoperatively decreased 
in 40% of the patients compared with the preoperative 
measurement. However, grip strength improved from 
preoperative levels in all patients who were followed 
up at 12 months postoperatively. Scar pain or tender-
ness may influence grip strength weakness at 6 months 
postoperatively.
The follow-up period in this study is limited to 1 year. 
Thus, whether NCS at 6 months postoperatively will be 
related to long-term (more than 1 year) follow-up was 
not determined. According to the preceding study, the 
clinical outcomes following surgical release improved 
up to 6 months postoperatively. The same outcome was 
obtained after 6 years [30]. De Kleermaeker et al. investi-
gated the long-term outcome after operation in patients 
with CTS at 8 months postoperatively and the median 
follow-up at 9 years. They reported that the most impor-
tant factor associated with the long-term outcome is 
treatment outcome after about 8 months, and its effect 
persists after 9 years [16]. Atroshi et  al. also reported 
the clinical outcome at 1 year postoperatively, which 
was maintained at the final follow-up (11–16 years) [31]. 
Although the evaluation of outcomes and NCS in this 
study was conducted within a year, clinical outcome 
prognosis at 1 year postoperatively may represent a long 
period of functional prognosis of more than 1 year.
Neurophysiological severity of CTS median nerve 
may affect postoperative clinical outcomes. The postop-
erative CMAP amplitude had significant correlation with 
change in the grip strength at 6 months postoperatively. 
However, there was no significant difference in postop-
erative clinical outcomes between the two groups divided 
by the lower limit of CMAP amplitudes in this study. We 
evaluated only the amplitude, though the amplitude and 
duration of CMAP are required to correctly distinguish 
between axonal loss and demyelinating conduction block. 
The limitation may have influenced on the outcomes.
Patients with unavailable NCS (MCV and SCV) wave-
form at the median nerve were excluded. Therefore, the 
very severe cases with no available waveform were not 
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included in this study. Thus, the result of this study may 
not be applied to patients with very severe CTS.
Conclusions
This study found that preoperative NCS is not used 
to predict postoperative clinical outcomes. However, 
the results of the 6 months postoperative NCS can pre-
dict the improvement in the DASH score at 12 months 
postoperatively.
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